[{"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "2450.00", "Date_of_Payment": "11/18/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104482262", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "2450.00", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104482258", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "2450.00", "Date_of_Payment": "10/16/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104482260", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "2450.00", "Date_of_Payment": "12/03/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104482266", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "2450.00", "Date_of_Payment": "09/24/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104482256", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "2450.00", "Date_of_Payment": "11/12/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104482264", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "1300.00", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104479402", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Aggrenox", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "1300.00", "Date_of_Payment": "09/23/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104479400", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "400", "Date_of_Payment": "03/25/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196064168", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "400", "Date_of_Payment": "04/10/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196064166", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "400", "Date_of_Payment": "04/09/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196064174", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "400", "Date_of_Payment": "03/17/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196064170", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "400", "Date_of_Payment": "09/04/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196064162", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "400", "Date_of_Payment": "04/01/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196064164", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "400", "Date_of_Payment": "02/06/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196064172", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "400", "Date_of_Payment": "10/30/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196064160", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "375.00", "Date_of_Payment": "09/11/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477716", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "09/10/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477202", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "10/02/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477206", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "10/18/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477212", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "08/29/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477200", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "12/10/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477216", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Aggrenox", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "08/01/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477194", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "09/17/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477208", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "12/17/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477220", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Aggrenox", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "10/18/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477214", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Aggrenox", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "08/13/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477196", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "08/22/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477198", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "10/21/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477210", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "12/19/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477218", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "09/18/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "104477204", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "300", "Date_of_Payment": "07/23/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "196021932", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "123.06", "Date_of_Payment": "10/16/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104472248", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "115.40", "Date_of_Payment": "08/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104470598", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PRADAXA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "115", "Date_of_Payment": "04/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156532906", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "100.37", "Date_of_Payment": "09/24/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104467324", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "90.59", "Date_of_Payment": "08/28/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23817217", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "89.07", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104464806", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Aggrenox", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "88.51", "Date_of_Payment": "09/03/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "100343196", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "86.25", "Date_of_Payment": "04/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156532904", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xarelto", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GENZYME CORPORATION", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000297", "Total_Amount_of_Payment_USDollars": "67.63", "Date_of_Payment": "08/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "188826776", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "AUBAGIO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "45.23", "Date_of_Payment": "09/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104459642", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "iowa neurology research, inc", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Novartis Pharmaceuticals Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000228", "Total_Amount_of_Payment_USDollars": "22.72", "Date_of_Payment": "11/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "152599102", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "EXELON PATCH", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "18.95", "Date_of_Payment": "10/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146693636", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIIBRYD", "Name_of_Associated_Covered_Drug_or_Biological2": "FETZIMA", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Supernus Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MD", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000011150", "Total_Amount_of_Payment_USDollars": "17.32", "Date_of_Payment": "10/02/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31963475", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TROKENDI XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Questcor Pharmaceuticals", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010569", "Total_Amount_of_Payment_USDollars": "17.02", "Date_of_Payment": "12/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "211688908", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ACTHAR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "14.29", "Date_of_Payment": "12/03/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104397906", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Biogen Idec Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000193", "Total_Amount_of_Payment_USDollars": "13.69", "Date_of_Payment": "11/07/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "23697974", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TECFIDERA", "Name_of_Associated_Covered_Drug_or_Biological2": "AVONEX", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Teva Pharmaceuticals USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000141", "Total_Amount_of_Payment_USDollars": "11.41", "Date_of_Payment": "10/31/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102187782", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "COPAXONE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Supernus Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MD", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000011150", "Total_Amount_of_Payment_USDollars": "11.14", "Date_of_Payment": "09/12/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "206988110", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TROKENDI XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "10.66", "Date_of_Payment": "09/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146693644", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Eisai Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000136", "Total_Amount_of_Payment_USDollars": "10.51", "Date_of_Payment": "04/17/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "184768828", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Fycompa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "8.50", "Date_of_Payment": "10/16/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104304850", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "8.37", "Date_of_Payment": "08/15/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "100343188", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "7.94", "Date_of_Payment": "11/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104302248", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Pradaxa", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "3.21", "Date_of_Payment": "12/20/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "100343194", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "2.46", "Date_of_Payment": "08/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "100343192", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "1.88", "Date_of_Payment": "04/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196064156", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIRAMUNE", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "1.88", "Date_of_Payment": "04/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196064154", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "TRADJENTA", "Name_of_Associated_Covered_Drug_or_Biological2": "APTIVUS", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000234", "Total_Amount_of_Payment_USDollars": "1.88", "Date_of_Payment": "04/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "196064158", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIRAMUNE", "Name_of_Associated_Covered_Drug_or_Biological2": "TRADJENTA", "Contextual_Information": ""}, {"Physician_Profile_ID": "333602", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "1.41", "Date_of_Payment": "11/27/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "100343190", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NAMENDA XR", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}]